Teva Pharmaceutical Industries
TEVA
$7.23
Share price
0.42%
Change (1 day)
-24.05%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Cash on Hand
Cash on Hand as of December 2022 : $2.80 B
According to Teva Pharmaceutical Industries's latest financial reports the company has $2.80 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Teva Pharmaceutical Industries - Cash on Hand chart (from 2001 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $2.80 B | 29.38% |
| 2021-12-31 | $2.16 B | -0.55% |
| 2020-12-31 | $2.17 B | 10.23% |
| 2019-12-31 | $1.97 B | 10.83% |
| 2018-12-31 | $1.78 B | 85.05% |
| 2017-12-31 | $0.96 B | -2.53% |
| 2016-12-31 | $0.98 B | -85.78% |
| 2015-12-31 | $6.94 B | 212.04% |
| 2014-12-31 | $2.22 B | 114.45% |
| 2013-12-31 | $1.03 B | -63.95% |
| 2012-12-31 | $2.87 B | 162.68% |
| 2011-12-31 | $1.09 B | -14.64% |
| 2010-12-31 | $1.28 B | -42.88% |
| 2009-12-31 | $2.24 B | 17.88% |
| 2008-12-31 | $1.90 B | -33.67% |
| 2007-12-31 | $2.87 B | 40.66% |
| 2006-12-31 | $2.04 B | -7.56% |
| 2005-12-31 | $2.21 B | 112.42% |
| 2004-12-31 | $1.04 B | -24.54% |
| 2003-12-31 | $1.37 B | 31.92% |
| 2002-12-31 | $1.04 B | 32.33% |
| 2001-12-31 | $0.79 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $12.26 B | 337.70% | 🇨🇭 Switzerland |
 Pfizer PFE | $22.73 B | 711.57% | 🇺🇸 USA |
 Sanofi SNY | $14.35 B | 412.35% | 🇫🇷 France |
 Merck MRK | $13.19 B | 370.97% | 🇺🇸 USA |
 AstraZeneca AZN | $6.46 B | 130.70% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $8.64 B | 208.47% | 🇬🇧 UK |
 Dr. Reddy's RDY | $0.60 B | -78.36% | 🇮🇳 India |